AMY COURTNEY's research topics

AMY COURTNEY

Concepts (148)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with AMY COURTNEY's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that AMY COURTNEY has written about over time.

AIDS Vaccines, 1 publications between 2009 and 2009, average publication date February 2009. HIV Antigens, 1 publications between 2009 and 2009, average publication date February 2009. Administration, Intranasal, 3 publications between 2007 and 2011, average publication date April 2009. Immunity, Mucosal, 3 publications between 2007 and 2011, average publication date April 2009. Adjuvants, Immunologic, 4 publications between 2009 and 2012, average publication date August 2010. Respiratory Mucosa, 1 publications between 2011 and 2011, average publication date September 2011. Galactosylceramides, 5 publications between 2009 and 2018, average publication date March 2012. Nanoparticles, 2 publications between 2009 and 2021, average publication date April 2015. Lymphocyte Activation, 9 publications between 2009 and 2023, average publication date April 2016. Natural Killer T-Cells, 13 publications between 2009 and 2023, average publication date December 2016. Gangliosides, 2 publications between 2014 and 2019, average publication date February 2017. Interleukin-15, 3 publications between 2012 and 2020, average publication date May 2017. Neuroblastoma, 9 publications between 2012 and 2023, average publication date May 2018. Cytotoxicity, Immunologic, 5 publications between 2014 and 2023, average publication date July 2018. Immunotherapy, Adoptive, 8 publications between 2012 and 2023, average publication date April 2019. Interleukins, 2 publications between 2018 and 2020, average publication date April 2019. Hematopoietic Stem Cell Transplantation, 1 publications between 2023 and 2023, average publication date February 2023. Receptors, Tumor Necrosis Factor, Type II, 1 publications between 2023 and 2023, average publication date February 2023.

AIDS Vaccines
HIV Antigens
Administration, Intranasal
Immunity, Mucosal
Adjuvants, Immunologic
Respiratory Mucosa
Galactosylceramides
Nanoparticles
Lymphocyte Activation
Natural Killer T-Cells
Gangliosides
Interleukin-15
Neuroblastoma
Cytotoxicity, Immunologic
Immunotherapy, Adoptive
Interleukins
Hematopoietic Stem Cell Transplantation
Receptors, Tumor Necrosis Factor, Type II

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
AIDS Vaccines	1	2009	2009	February 2009
HIV Antigens	1	2009	2009	February 2009
Administration, Intranasal	3	2007	2011	April 2009
Immunity, Mucosal	3	2007	2011	April 2009
Adjuvants, Immunologic	4	2009	2012	August 2010
Respiratory Mucosa	1	2011	2011	September 2011
Galactosylceramides	5	2009	2018	March 2012
Nanoparticles	2	2009	2021	April 2015
Lymphocyte Activation	9	2009	2023	April 2016
Natural Killer T-Cells	13	2009	2023	December 2016
Gangliosides	2	2014	2019	February 2017
Interleukin-15	3	2012	2020	May 2017
Neuroblastoma	9	2012	2023	May 2018
Cytotoxicity, Immunologic	5	2014	2023	July 2018
Immunotherapy, Adoptive	8	2012	2023	April 2019
Interleukins	2	2018	2020	April 2019
Hematopoietic Stem Cell Transplantation	1	2023	2023	February 2023
Receptors, Tumor Necrosis Factor, Type II	1	2023	2023	February 2023

COURTNEY's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (148)

Explore

Co-Authors (24)

Explore

Similar People (60)

Explore

Same Department

Explore